Company / Share Buybacks
Bio-Techne Share Buybacks History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$275.7M
FY2025
5-year range
$15.4M / $275.7M
FY2021-FY2025
Trend
+244.5%
vs FY2024
Sector context
#44 of 101
Health Care
What the data says
Share Buybacks changed +244% YoY in FY2025, a notable deviation from the 6-year average annual change of +116%.
Based on SEC 10-K filings.
$276M in FY2025 with a 5-year CAGR of +40.6%.
Improved from $43M to $276M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- +76.5%
- 5-Year CAGR
- +40.6%
- 10-Year CAGR
- -
Sector benchmark
#44 of 101 in Health CareTop 44% of 101This company $275.7M Sector average $570.7M
▼
-51.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.6%, indicating consistent growth.
- In FY2025, share buybacks increased 244.5% year-over-year.
- Ranks #44 out of 101 companies in the Health Care sector.
- Lowest share buybacks in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $275.7M | +244.5% |
| FY2024 | $80.0M | +85.4% |
| FY2023 | $43.2M | -13.8% |
| FY2022 | $50.1M | +225.3% |
| FY2021 | $15.4M | -69.3% |
| FY2020 | $50.1M | +225.3% |
| FY2019 | $15.4M | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026